Is the Options Market Predicting a Spike in Haemonetics Stock?
Haemonetics Corp HAE
$56.29
βΌ -1.45%
($-0.83)
Open
$57.27
Prev Close
$57.12
Day Range
$56.26 β $58.18
52W Range
$47.32 β $87.32
Market Cap
$2.62B
P/E (TTM)
14.91
Beta
0.50
EPS (TTM)
$3.64
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1979-10-17 |
| Shares Out. | 46,470,000 |
| Website | haemonetics.com β |
| Phone | 17818487100 |
Haemonetics Corp is a publicly traded company under the ticker symbol HAE on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
15 analysts (2026-05-01)
π° Latest News for HAE
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
Barrington Research Maintains Outperform on Haemonetics, Lowers Price Target to $89
Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness
Transcript : Haemonetics Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut
Haemonetics Corporation 2026 Q4 - Results - Earnings Call Presentation
